iShares Core S&P 500 ETF · $850B$17,151
IVVIVV vsBBCBBCVirtus Biotech Clinical Trials ETF · $34M$9,380
$10,000 five years ago, dividends reinvested · they hold 0.0% in common
IVVMeasureBBC
Returns · dividends reinvested
+8.4%Year to dateJan 1 → Nov 5+5.6%
+9.7%1 yearTotal return+36.3%
+22.1%3 years · per year$10,000 became $18,221 · $23,503+33.0%
+11.4%5 years · per year$10,000 became $17,151 · $9,380−1.3%
Cost and income
0.03%Expense ratio$3 · $65 a year on $10k · lower is better0.65%
1.14%Trailing 12-mo yield$114 · $161 a year on $10k1.61%
Risk · past year
−8.9%Worst dropSmaller is better−30.2%
13.6%VolatilityLower is calmer38.2%
IVVBBC Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3IVV wins
End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns